SARS Breadcrumb Home Glossary SARS Short description The severe acute respiratory syndrome (SARS) is an infectious disease caused by the SARS-associated coronavirus. It has similar symptoms as the flu. Detailed description SARS was observed for the first time in 2002 when an epidemic originating in China affected the whole world. More about “SARS” Jun 2021 Proc Natl Acad Sci U S A Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination Autoren Tscherne A et al. May 2021 J Clin Med Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies Autoren Kohmer N et al. Jun 2021 BMC Infect Dis Web-based, rapid and contactless management of ambulatory patients for SARS-CoV-2-testing Autoren Stemler J et al. May 2021 PLoS One The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use Autoren Krüger LJ et al. Jun 2021 Infection SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study) Autoren van Bremen K et al. May 2021 Graefes Arch Clin Exp Ophthalmol No secret hiding place on the ocular surface: what about after systemic SARS-CoV-2 infection? Autoren Rokohl AC et al. Jun 2021 J Med Virol Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent Autoren Abe H et al. May 2021 Infection Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing Autoren Würstle S et al. Jun 2021 Lancet Microbe SARS-CoV-2 emerging variants in Africa: view from Gabon Autoren Zoa-Assoumou S et al. May 2021 Cell Host Microbe Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans Autoren Vanshylla K et al. Pagination < previous Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page ››
Jun 2021 Proc Natl Acad Sci U S A Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination Autoren Tscherne A et al.
May 2021 J Clin Med Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies Autoren Kohmer N et al.
Jun 2021 BMC Infect Dis Web-based, rapid and contactless management of ambulatory patients for SARS-CoV-2-testing Autoren Stemler J et al.
May 2021 PLoS One The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use Autoren Krüger LJ et al.
Jun 2021 Infection SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study) Autoren van Bremen K et al.
May 2021 Graefes Arch Clin Exp Ophthalmol No secret hiding place on the ocular surface: what about after systemic SARS-CoV-2 infection? Autoren Rokohl AC et al.
Jun 2021 J Med Virol Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent Autoren Abe H et al.
May 2021 Infection Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing Autoren Würstle S et al.
Jun 2021 Lancet Microbe SARS-CoV-2 emerging variants in Africa: view from Gabon Autoren Zoa-Assoumou S et al.
May 2021 Cell Host Microbe Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans Autoren Vanshylla K et al.
